Invariant NKT Cells and Tolerance

REFERENCES

• M. Emoto and S.H. Kaufmann, Liver NKT cells: An account of heterogeneity, Trends Immunol., 24: 364–369, 2003.
   PubMed Web of Science ®Google Scholar
• A. Bendelac, M.N. Rivera, S.H. Park, and J.H. Roark, Mouse CD1-specific NK1 T cells: Development, specificity, and function, Annu. Rev. Immunol., 15: 535–562, 1997.
   PubMed Web of Science ®Google Scholar
• M. Emoto, Y. Emoto, and S.H.E. Kaufmann, Interleukin-4-producing CD4+ NK1.1+ TCRα/β intermediate liver lymphocytes are down-regulated by Listeria monocytogenes, Eur. J. Immunol., 25: 3321–3325, 1995.
   Google Scholar
• M. Emoto, Y. Emoto, and S.H.E. Kaufmann, IL-4 producing CD4+ TCRαβint liver lymphocytes: Influence of thymus, β2-microglobulin and NK1.1 expression, Int. Immunol., 7(11): 1729–1739, 1995.
   Google Scholar
• S.K. Mendiratta, W.D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer, CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity, 6: 469–477, 1997.
   PubMed Web of Science ®Google Scholar
• D.I. Godfrey, J. McCluskey, and J. Rossjohn, CD1d antigen presentation: Treats for NKT cells, Nat. Immunol., 6: 754–756, 2005.
   PubMed Web of Science ®Google Scholar
• V.V. Parekh, M.T. Wilson, and L. Van Kaer, iNKT-cell responses to glycolipids, Crit. Rev. Immunol., 25: 183–213, 2005.
   PubMed Web of Science ®Google Scholar
• D. Zhou, J. Mattner, and C. Cantu, 3rd, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y.P. Wu, T. Yamashita, S. Teneberg, D. Wang, R.L. Proia, S.B. Levery, P.B. Savage, L. Teyton, and A. Bendelac, Lysosomal glycosphingolipid recognition by NKT cells, Science, 306: 1786–1789, 2004.
   PubMed Web of Science ®Google Scholar
• D.M. Zajonc, C. Cantu, 3rd, J. Mattner, D. Zhou, P.B. Savage, A. Bendelac, I.A. Wilson, and L. Teyton, Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor, Nat. Immunol., 6: 810–818, 2005.
   PubMed Web of Science ®Google Scholar
• T. Kawano, J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, H. Koseki, and M. Taniguchi, CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science, 278: 1626–1629, 1997.
   PubMed Web of Science ®Google Scholar
• A. Shimosaka, Role of NKT cells and alpha-galactosyl ceramide, Int. J. Hematol., 76 (Suppl 1): 277–279, 2002.
   Google Scholar
• R. Nakagawa, I. Serizawa, K. Motoki, M. Sato, H. Ueno, R. Iijima, H. Nakamura, A. Shimosaka, and Y. Koezuka, Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells, Oncol. Res., 12: 51–58, 2000.
   Google Scholar
• R. Nakagawa, K. Motoki, H. Ueno, R. Iijima, H. Nakamura, E. Kobayashi, A. Shimosaka, and Y. Koezuka, Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000, Cancer Res., 58: 1998.
   Google Scholar
• K. Sato, K. Ohtsuka, K. Hasegawa, S. Yamagiwa, H. Watanabe, H. Asakura, and T. Abo, Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation, J. Exp. Med., 182: 759–767, 1995.
   Google Scholar
• M.C. Coles and D.H. Raulet, NK1.1+T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+cells, J. Immunol., 164: 2412–2418, 2000.
   Google Scholar
• K. Hammond, W. Cain, I. van Driel, and D. Godfrey, Three day neonatal thymectomy selectively depletes NK1.1+ T cells, Int. Immunol., 10: 1491–1499, 1998.
   PubMed Web of Science ®Google Scholar
• F. Tilloy, J.P. Di Santo, A. Bendelac, and O. Lantz, Thymic dependence of invariant Valpha14+ natural killer-T cell development, Eur. J. Immunol., 29:3313–3318, 1999.
   Google Scholar
• A. Bendelac, N. Killeen, D.R. Littman, and R.H. Scwartz, A subset of CD4+ thymocytes selected by MHC class I molecule, Science, 263: 1774–1778, 1994.
   PubMed Web of Science ®Google Scholar
• S. Toyabe, S. Seki, T. Iiai, K. Takeda, K. Shirai, H. Watanabe, H. Hiraide, M. Uchiyama, and T. Abo, Requirement of IL-4 and liver NK1+T cells for concanavalin A-induced hepatic injury in mice, J. Immunol., 159: 1537–1542, 1997.
   PubMedGoogle Scholar
• K. Takeda, Y. Hayakawa, L. Van Kaer, H. Matsuda, H. Yagita, and K. Okumura, Critical contribution of liver natural killer T cells to a murine model of hepatitis, Proc. Natl. Acad. Sci. U. S. A., 97: 5498–5503, 2000.
   PubMed Web of Science ®Google Scholar
• Y. Kaneko, M. Harada, T. Kawano, M. Yamashita, Y. Shibata, F. Gejyo, T. Nakayama, and M. Taniguchi, Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis, J. Exp. Med., 191: 105–114, 2000.
   PubMed Web of Science ®Google Scholar
• H. Louis, A. Le Moine, V. Flamand, N. Nagy, E. Quertinmont, F. Paulart, D. Abramowicz, O. Le Moine, M. Goldman, and J. Deviere, Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice, Gastroenterology, 122: 2001–2010, 2002.
   PubMed Web of Science ®Google Scholar
• O. Akbari, P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M.J. Grusby, R.H. DeKruyff, and D.T. Umetsu, Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity, Nat. Med., 9: 582–588, 2003.
   PubMed Web of Science ®Google Scholar
• K.-H. Sonoda, M. Exley, S. Snapper, S. Balk, and J. Stein-Streilein, CD1 reactive NKT cells are required for development of systemic tolerance through an immune privileged site, J. Exp. Med., 190: 1215–1225, 1999.
   PubMed Web of Science ®Google Scholar
• D. Zeng, D. Lewis, S. Dejbakhsh-Jones, F. Lan, M. Garcia-Ojeda, R. Sibley, and S. Strober, Bone marrow NK1.1(−) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease, J. Exp. Med., 189: 1073–1081, 1999.
   PubMed Web of Science ®Google Scholar
• H.J. Kaplan and J.W. Streilein, Do immunological privileged sites require a functioning spleen? Nature, 251: 553–554, 1974.
   PubMed Web of Science ®Google Scholar
• H.J. Kaplan, J.W. Streilein, and T.R. Stevens, Transplantation immunology of the anterior chamber of the eye. II. Immune response to allogeneic cells, J. Immunol., 118: 809–814, 1975.
   Google Scholar
• J. Niederkorn, J.W. Streilein, and J.A. Shadduck, Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice, Invest. Ohthalmol. Vis. Sci., 20: 355–363, 1980.
   Google Scholar
• K.H. Sonoda and J. Stein-Streilein, Ocular immune privilege and CD1d-reactive natural killer T cells. Cornea, 21: S33–38, 2002.
   PubMedGoogle Scholar
• J. Stein-Streilein and J.W. Streilein, Anterior chamber associated immune deviation (ACAID); regulation, biological relevance, and implications for therapy, Int. Rev. Immunol., 21: 123–152, 2002.
   PubMedGoogle Scholar
• J.W. Streilein, Ocular immune privilege: therapeutic opportunities from an experiment of nature, Nat. Rev. Immunol., 3: 878–889, 2003.
   Google Scholar
• J.W. Streilein and J.Y. Niederkorn, Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells, J. Immunol., 134: 1381–1387, 1985.
   PubMed Web of Science ®Google Scholar
• G.A. Wilbanks and J.W. Streilein, Studies on the induction of anterior chamber-associated immune deviation (ACAID). I. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood, J. Immunol., 146: 2610–2617, 1991.
   PubMed Web of Science ®Google Scholar
• G.A. Wilbanks, M. Mammolenti, and J. Streilein, Studies on the induction of anterior chamber associated immune deviation (ACAID). II. Eye derived cells participate in gerating blood-borne signals that induce ACAID, J. Immunol., 146: 3018–3024, 1991.
   PubMed Web of Science ®Google Scholar
• G.A. Wilbanks, M. Mammolenti, and J.W. Streilein, Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta, Eur. J. Immunol., 22: 165–173, 1992.
   PubMed Web of Science ®Google Scholar
• D.E. Faunce, K.-H. Sonoda, and J. Stein-Streilein, MIP-2 recruits NKT cells to the spleen during tolerance induction, J. Immunol., 166: 313–321, 2001.
   PubMed Web of Science ®Google Scholar
• D.E. Faunce and J. Stein-Streilein, NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance, J. Immunol., 169: 31–38, 2002.
   PubMed Web of Science ®Google Scholar
• K.-H. Sonoda, D.E. Faunce, M. Taniguchi, M. Exley, S. Balk, and J. Stein-Streilein, NKT cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance, J. Immunol., 166: 42–50, 2001.
   PubMed Web of Science ®Google Scholar
• J. Stein-Streilein, K.-H. Sonoda, D. Faunce, and J. Zhang-Hoover, Regulation of adaptive immune responses by innate cells expressing NK markers and antigen-transporting macrophages, J. Leukoc. Biol., 67: 488–494, 2000.
   Google Scholar
• S. Masli, B. Turpie, and J.W. Streilein, Thrombospondin orchestrates the tolerance-promoting properties of TGF{beta}-treated antigen-presenting cells. Int. Immunol., 18: 689–699, 2006.
   PubMed Web of Science ®Google Scholar
• T. Nakamura, K.H. Sonoda, D.E. Faunce, J. Gumperz, T. Yamamura, S. Miyake, and J. Stein-Streilein, CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune privileged site, J. Immunol., 171: 1266–1271, 2003.
   PubMed Web of Science ®Google Scholar
• T. Nakamura, A. Terajewicz, and J. Stein-Streilein, Mechanisms of peripheral tolerance following intracameral inoculation are independent of IL-13 or Stat 6, J. Immunol., 175: 2643–2646, 2005.
   Google Scholar
• J.Y. Niederkorn, Immune privilege in the anterior chamber of the eye, Crit. Rev. Immunol., 22: 13–46, 2002.
   PubMed Web of Science ®Google Scholar
• K.-H. Sonoda, M. Taniguchi, and J. Stein-Streilein, Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells, J. Immunol., 168: 2028–2034, 2002.
   PubMed Web of Science ®Google Scholar
• F. Lan, D. Zeng, M. Higuchi, P. Huie, J.P. Higgins, and S. Strober, Predominance of NK1.1+TCRalphaß+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: “natural suppressor” cells, J. Immunol., 167: 2087–2096, 2001.
   PubMed Web of Science ®Google Scholar
• M. Higuchi, D. Zeng, J. Shizuru, J. Gworek, S. Dejbakhsh-Jones, M. Taniguchi, and S. Strober, Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion, J. Immunol., 169: 5564–5570, 2002.
   PubMed Web of Science ®Google Scholar
• F. Lan, D. Zeng, M. Higuchi, J.P. Higgins, and S. Strober, Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: The role of CD1-reactive natural killer T cells, Biol. Blood Marrow Transplant., 9: 355–363, 2003.
   PubMed Web of Science ®Google Scholar
• H. Li, J.Y. Niederkorn, S. Neelam, and H. Alizadeh, Downregulation of surviving expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment, Exp. Eye Res., 2006.
   Google Scholar
• Y. Ikehara, Y. Yasunami, S. Kodama, T. Maki, M. Nakano, T. Nakayama, M. Taniguchi, and S. Ikeda, CD4(+) Valpha 14 natural killer T cells are essential for acceptance of rat islet xenografts in mice, J. Clin. Invest., 105: 1761–1767, 2000.
   PubMed Web of Science ®Google Scholar
• K.K. Seino, K. Fukao, K. Muramoto, K. Yanagisawa, Y. Takada, T. Katuta, Y. Iwakura, L. Van Kaer, K. Takeda, T. Nakayama, M. Taniguchi, H. Bashuda, H. Yagita, and K. Okumura, Requirement for natural killer T (NKT) cells in the induction of allograft tolerance, Proc. Natl. Acad. Sci. U. S. A., 98: 2577–2581, 2001.
   PubMed Web of Science ®Google Scholar
• S.P. Cobbold, A. Jayasuriya, A. Nash, T.D. Prospero, and H. Waldmann, Therapy with monoclonal antibodies by elimination of t-cell subsets in vivo, Nature, 312: 548–551, 1984.
   PubMed Web of Science ®Google Scholar
• S.P. Cobbold, K.F. Nolan, L. Graca, R. Castejon, A. Le Moine, M. Frewin, S. Humm, E. Adams, S. Thompson, D. Zelenika, A. Paterson, S. Yates, P.J. Fairchild, and H. Waldmann, Regulatory T cells and dendritic cells in transplantation tolerance: Molecular markers and mechanisms, Immunol. Rev., 196: 109–124, 2003.
   PubMed Web of Science ®Google Scholar
• J. Ermann, P. Hoffmann, M. Edinger, S. Dutt, F.G. Blankenberg, J.P. Higgins, R.S. Negrin, C.G. Fathman, and S. Strober, Only the CD62L+subpopulation of CD4+CD25+regulatory T cells protects from lethal acute GVHD, Blood, 105: 2220–2226, 2005.
   PubMed Web of Science ®Google Scholar
• A.L. Cava, L.V. Kaer, and S. Fu Dong, CD4(+)CD25(+) Tregs and NKT cells: Regulators regulating regulators, Trends Immunol., 27(7): 322–327, 2006.
   Google Scholar
• R. Liu, A. La Cava, X.F. Bai, Y. Jee, M. Price, D.I. Campagnolo, P. Christadoss, T.L. Vollmer, L. Van Kaer, and F.D. Shi, Cooperation of invariant NKT cells and CD4+CD25+T regulatory cells in the prevention of autoimmune myasthenia, J. Immunol., 175: 7898–7904, 2005.
   PubMed Web of Science ®Google Scholar
• W. Li, K. Carper, and J.D. Perkins, Enhancement of NKT cells and increase in regulatory T cells results in improved allograft survival, J. Surg. Res., 2006.
   Google Scholar
• T.B. Tomasi, Jr., Oral tolerance. Transplantation, 29: 353–356, 1980.
   PubMedGoogle Scholar
• S.J. Khoury, W.W. Hancock, and H.L. Weiner, Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain, J. Exp. Med., 176: 1355–1364, 1992.
   PubMed Web of Science ®Google Scholar
• H.J. Kim, S.J. Hwang, B.K. Kim, K.C. Jung, and D.H. Chung, NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells, Immunology, 118: 101–111, 2006.
   Google Scholar
• S. Artik, K. Haarhuis, X. Wu, J. Begerow, and E. Gleichmann, Tolerance to nickel: Oral nickel administration induces a high frequency of anergic T cells with persistent suppressor activity, J. Immunol., 167: 6794–6803, 2001.
   PubMed Web of Science ®Google Scholar
• K. Roelofs-Haarhuis, X. Wu, M. Nowak, M. Fang, S. Artik, and E. Gleichmann, Infectious nickel tolerance: A reciprocal interplay of tolerogenic APCs and T suppressor cells that is driven by immunization, J. Immunol., 171: 2863–2872, 2003.
   PubMed Web of Science ®Google Scholar
• K. Roelofs-Haarhuis, X. Wu, and E. Gleichmann, Oral tolerance to nickel requires CD4+invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells, J. Immunol., 173: 1043–1050, 2004.
   PubMed Web of Science ®Google Scholar
• M. Nowak, F. Kopp, K. Roelofs-Haarhuis, X. Wu, and E. Gleichmann, Oral nickel tolerance: Fas ligand-expressing invariant NK T cells promote tolerance induction by eliciting apoptotic death of antigen-carrying, effete B cells, J. Immunol., 176: 4581–4589, 2006.
   Google Scholar
• T.A. Ferguson, J. Herndon, B. Elzey, T.S. Griffith, S. Schoenberger, and D.R. Green, Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8+T cells produce active immune unresponsiveness, J. Immunol., 168: 5589–5595, 2002.
   PubMed Web of Science ®Google Scholar
• Y.N. Naumov, K.S. Bahjat, R. Gausling, R. Abraham, M.A. Exley, Y. Koezuka, S.B. Balk, J.L. Strominger, M. Clare-Salzer, and S.B. Wilson, Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets, Proc. Natl. Acad. Sci. U. S. A, 98: 13838–13843, 2001.
   PubMed Web of Science ®Google Scholar
• Y. Kaneko, M. Harada, T. Kawano, M. Yamashita, Y. Shibata, F. Gejyo, T. Nakayama, and M. Taniguchi, Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis, J. Exp. Med., 191: 105–114, 2000.
   PubMed Web of Science ®Google Scholar
• D.E. Faunce, K.H. Sonoda, and J. Stein-Streilein, MIP-2 recruits NKT cells to the spleen during tolerance induction, J. Immunol., 166: 313–321, 2001.
   PubMed Web of Science ®Google Scholar
• K.-H. Sonoda and J. Stein-Streilein, CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance, Eur. J. Immunol., 32: 848–857, 2002.
   PubMed Web of Science ®Google Scholar
• D.E. Faunce and J. Stein-Streilein, NKT cell-derived RANTES recruits APCs and CD8+T cells to the spleen during the generation of regulatory T cells in tolerance, J. Immunol., 169: 31–38, 2002.
   PubMed Web of Science ®Google Scholar
• J. Stein-Streilein, A privileged view of NKT cells and peripheral tolerance through the eye, Ocul. Immunol. Inflamm., 13: 111–117, 2005.
   PubMed Web of Science ®Google Scholar
• J.Y. Niederkorn, See no evil, hear no evil, do no evil: The lessons of immune privilege, Nat. Immunol., 7: 354–359, 2006.
   PubMed Web of Science ®Google Scholar
• A.G. Baxter, S.J. Kinder, K.J. Hammond, R. Scollay, and D.I. Godfrey, Association between alphabetaTCR+CD4−CD8− T-cell deficiency and IDDM in NOD/Lt mice, Diabetes, 46: 572–582, 1997.
   PubMed Web of Science ®Google Scholar
• S. Makino, K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino, Breeding of a non-obese, diabetic strain of mice, Jikken Dobutsu, 29: 1–13, 1980.
   PubMedGoogle Scholar
• L.D. Poulton, M.J. Smyth, C.G. Hawke, P. Silveira, D. Shepherd, O.V. Naidenko, D.I. Godfrey, and A.G. Baxter, Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice, Int. Immunol., 13: 887–896, 2001.
   PubMedGoogle Scholar
• J.M. Gombert, A. Herbelin, E. Tancrede-Bohin, M. Dy, C. Carnaud, and J.F. Bach, Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse, Eur. J. Immunol., 26: 2989–2998, 1996.
   PubMed Web of Science ®Google Scholar
• K.J.L. Hammond, L.D. Poulton, L.J. Palmisano, P.A. Silveira, D.I. Godfrey, and A.G. Baxter, Alpha/beta-T cell receptor (TCR)+CD4−CD8− (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10, J. Exp. Med., 187: 1047–1056, 1998.
   PubMed Web of Science ®Google Scholar
• V. Laloux, L. Beaudoin, D. Jeske, C. Carnaud, and A. Lehuen, NK T cell-induced protection against diabetes in Valpha14-Jalpha281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen, J. Immunol., 166: 3749–3756, 2001.
   PubMedGoogle Scholar
• S. Hong, M.T. Wilson, I. Serizawa, L. Wu, N. Singh, O.V. Naidenko, T. Miura, T. Haba, D.C. Scherer, J. Wei M. Kronenberg, and L. Van Kaer, The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice, Nat. Med., 7: 1052–1056, 2001.
   PubMed Web of Science ®Google Scholar
• S. Sharif, G.A. Arreaza, P. Zucker, Q.S. Mi, J. Sondhi, O.V. Naidenko, M. Kronenberg, Y. Koezuka, T.L. Delovitch, J.M. Gombert, M. Leite-De-Moraes, C. Gouarin, R. Zhu, A. Hameg, T. Nakayama, M. Taniguchi, F. Lepault, A. Lehuen, J.F. Bach, and A. Herbelin, Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes, Nat. Med., 7: 1057–1062, 2001.
   PubMed Web of Science ®Google Scholar
• S.B. Wilson, S.C. Kent, K.T. Patton, T. Orban, R.A. Jackson, M. Exley, S. Porcelli, D.A. Schatz, M.A. Atkinson, S.P. Balk, J.L. Strominger, and D.A. Hafler, Extreme Th1 bias of invariant V□24J□Q T cells in type 1 diabetes [published erratum appears in Nature 1999;399 (6731): 84]. Nature, 391: 177–181, 1998.
   PubMed Web of Science ®Google Scholar
• F.D. Shi, M. Flodstrom, B. Balasa, S.H. Kim, K. Van Gunst, J.L. Strominger, S.B. Wilson, and N. Sarvetnick, Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse, Proc. Natl. Acad. Sci. U. S. A., 98: 6777–6782, 2001.
   PubMed Web of Science ®Google Scholar
• Y.G. Chen, C.M. Choisy-Rossi, T.M. Holl, H.D. Chapman, G.S. Besra, S.A. Porcelli, D.J. Shaffer, D. Roopenian, S.B. Wilson, and D.V. Serreze, Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes, J. Immunol., 174: 1196–1204, 2005.
   PubMed Web of Science ®Google Scholar
• L. Steinman, Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis, J. Exp. Med., 194: F27–F30, 2001.
   Web of Science ®Google Scholar
• L. Steinman, Multiple sclerosis: A two stage disease. Nat. Immunol., 2: 762–764, 2001.
   PubMed Web of Science ®Google Scholar
• T. Sumida, A. Sakamoto, H. Murata, Y. Makino, H. Takahashi, S. Yoshida, K. Nishioka, I. Iwamoto, and M. Taniguchi, Selective reduction of T cells bearing invariant V□24J□Q antigen receptor in patients with systemic sclerosis, J. Exp. Med., 182: 1163–1168, 1995.
   PubMed Web of Science ®Google Scholar
• S. Kojo, Y. Adachi, H. Keino, M. Taniguchi, and T. Sumida, Dysfunction of T cell receptor AV24AJ18+, BV11+double negative regulatory natural killer T cells in autoimmune diseases, Arthritis Rheum., 44: 1127–1138, 2001.
   PubMed Web of Science ®Google Scholar
• M. Araki, T. Kondo, J.E. Gumperz, M.B. Brenner, S. Miyake, and T. Yamamura, T h 2 bias of CD4+NKT cells derived from multiple sclerosis in remission, Int. Immunol., 15: 279–288, 2003.
   PubMed Web of Science ®Google Scholar
• S.L. van Dommelen, H.A. Tabarias, M.J. Smyth, and M.A. Degli-Esposti, Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells, J. Virol., 77: 1877–1884, 2003.
   PubMed Web of Science ®Google Scholar
• R. Furlan, A. Bergami, D. Cantarella, A. Brambilla, M. Taniguchi, P. Belladonna, G. Casorati, and G. Martino, Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35–55-induced EAE: Critical roles for administration route and IFN-gamma, Eur. J. Immunol., 33: 1830–1838, 2003.
   PubMed Web of Science ®Google Scholar
• J.S. Yang, L.-Y. Xu, Y.M. Huang, P.H. Van Der Meide, H. Link, and B.G. Xiao, Adherent dendritic cells expressing high levels of interleukin-10 and low levels of interleukin-12 induce antigen-specific tolerance to experimental autoimmune encephalomyelitis, Immunology, 101: 397–403, 2000.
   PubMedGoogle Scholar
• A.K. Singh, M.T. Wilson, S. Hong, D. Olivares-Villagomez, C. Du, A.K. Stanic, S. Joyce, S. Sriram, Y. Koezuka, and L. Van Kaer, Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis, J. Exp. Med., 194: 1801–1811, 2001.
   PubMed Web of Science ®Google Scholar
• E. Pal, T. Tabira, T. Kawano, M. Taniguchi, S. Miyake, and T. Yamamura, Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells, J. Immunol., 166: 662–668, 2001.
   PubMed Web of Science ®Google Scholar
• K. Miyamoto, S. Miyake, and T. Yamamura, A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells, Nature, 413: 531–534, 2001.
   PubMed Web of Science ®Google Scholar
• L.T. Mars, V. Laloux, K. Goude, S. Desbois, A. Saoudi, L. Van Kaer, H. Lassmann, A. Herbelin, A. Lehuen, and R. Liblau, Cutting edge: V alpha 14-Jalpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice, J. Immunol., 168: 6007–6011, 2002.
   PubMed Web of Science ®Google Scholar
• A.W. Jahng, I. Maricic, B. Pedersen, N. Burdin, O. Naidenko, M. Kronenberg, Y. Koezuka, and V. Kumar, Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis, J. Exp. Med., 194: 1789–1799, 2001.
   PubMed Web of Science ®Google Scholar
• D.E. Faunce, A. Terajewicz, and J. Stein-Streilein, Cutting edge: In vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis, J. Immunol., 172: 1991–1995, 2004.
   PubMed Web of Science ®Google Scholar
• F. Van de Keere and S. Tonegawa, CD4+ T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice, J. Exp. Med., 188: 1875–1882, 1998.
   PubMedGoogle Scholar
• C.R. Berkers and H. Ovaa, Immunotherapeutic potential for ceramide-based activators of iNKT cells, Trends Pharmacol. Sci., 26: 252–257, 2005.
   PubMed Web of Science ®Google Scholar
• J. Schmieg, G. Yang, R.W. Franck, and M. Tsuji, Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-galactosylceramide, J. Exp. Med., 198: 1631–1641, 2003.
   PubMed Web of Science ®Google Scholar
• B. Cipriani, L. Chen, K. Hiromatsu, H. Knowles, C.S. Raine, L. Battistini, S.A. Porcelli, and C.F. Brosnan, Upregulation of group 1 CD1 antigen presenting molecules in guinea pigs with experimental autoimmune encephalomyelitis: an immunohistochemical study, Brain Pathol., 13: 1–9, 2003.
   PubMed Web of Science ®Google Scholar
• G. Pawelec, R. Solana, E. Remarque, and E. Mariani, Impact of aging on innate immunity, J. Leukoc. Biol., 64: 703–712, 1998.
   PubMed Web of Science ®Google Scholar
• R. Solana and G. Pawelec, Molecular and cellular basis of immunosenescence, Mech. Ageing Dev., 102: 115–129, 1998.
   PubMedGoogle Scholar
• G. Pawelec, E. Remarque, Y. Barnett, and R. Solana, T cells and aging, Front Biosci., 3: d59–99, 1998.
   Google Scholar
• A. Globerson and R.B. Effros, Ageing of lymphocytes and lymphocytes in the aged, Immunol. Today, 21: 515–521, 2000.
   PubMedGoogle Scholar
• D.E. Faunce, J.L. Palmer, K.K. Paskowicz, P.L. Witte, and E.J. Kovacs, CD1d-restricted NKT cells contribute to the age-associated decline of T cell immunity, J. Immunol., 175: 3102–3109, 2005.
   Google Scholar
• J.L. Matsuda, L. Gapin, J.L. Baron, S. Sidobre, D.B. Stetson, M. Mohrs, R.M. Locksley, and M. Kronenberg, Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo, Proc. Natl. Acad. Sci. U. S. A., 100: 8395–8400, 2003.
   PubMed Web of Science ®Google Scholar
• J. Zhang-Hoover, P. Finn, and J. Stein-Streilein, Modulation of ovalbumin-induced airway inflammation and hyperreactivity by tolerogenic APC, J. Immunol., 175: 7117–7124, 2005.
   Google Scholar
• J. Zhang-Hoover and J. Stein-Streilein, Tolerogenic APC generate CD8+ T regulatory cells that modulate pulmonary interstitial fibrosis, J. Immunol., 172: 178–185, 2004.
   Google Scholar
• K. Katagiri, J. Zhang-Hoover, J.S. Mo, J. Stein-Streilein, and J.W. Streilein, Using tolerance induced via the anterior chamber of the eye to inhibit Th2-dependent pulmonary pathology, J. Immunol., 169: 84–89, 2002.
   PubMed Web of Science ®Google Scholar
• S. Sharif, A. G.A., P. Zucker, Q.S. Mi, and T.L. Delovitch, Regulation of autoimmune disease by natural killer T cells, J. Mol. Med., 80: 290–300, 2002.
   Google Scholar
• N.Y. Crowe, A.P. Uldrich, K. Kyparissoudis, K.J. Hammond, Y. Hayakawa, S. Sidobre, R. Keating, M. Kronenberg, M.J. Smyth, and D.I. Godfrey, Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells, J. Immunol., 171: 4020–4027, 2003.
   PubMed Web of Science ®Google Scholar
• R.M. Ndonye, D.P. Izmirian, M.F. Dunn, K.O. Yu, S.A. Porcelli, A. Khurana, M. Kronenberg, S.K. Richardson, and A.R. Howell, Synthesis and evaluation of sphinganine analogues of KRN7000 and OCH, J. Org. Chem., 70: 10260–10270, 2005.
   Google Scholar
• M. Mizuno, M. Masumura, C. Tomi, A. Chiba, S. Oki, T. Yamamura, and S. Miyake, Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice, J. Autoimmun., 23: 293–300, 2004.
   PubMed Web of Science ®Google Scholar
• J.Q. Yang, T. Chun, H. Liu, S. Hong, H. Bui, L. Van Kaer, C.R. Wang, and R.R. Singh, CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice, Eur. J. Immunol., 34: 1723–1732, 2004.
   Google Scholar
• E.E.S. Nieuwenhuis, T. Matsumoto, M. Exley, R.A. Schleipman, J. Glickman, D.T. Bailey, N. Corazza, S.P. Colgan, A.B. Onderdonk, and R.S. Blumberg, CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung, Nat. Med., 8: 588–593, 2002.
   PubMed Web of Science ®Google Scholar
• P.A. Sieling, D. Jullien, M. Dahlem, T.F. Tedder, T.H. Rea, R.L. Modlin, and S.A. Porcelli, CD1 expression by dendritic cells in human leprosy lesions: Correlation with effective host immunity, J. Immunol., 162: 1851–1858, 1999.
   PubMed Web of Science ®Google Scholar
• J.H. Roark, S.H. Park, J. Jayawardena, U. Kavita, M. Shannon, and A. Bendelac, CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells, J. Immunol, 160: 3121–3127, 1998.
   PubMed Web of Science ®Google Scholar
• J. Mattner, K.L. Debord, N. Ismail, R.D. Goff, C. Cantu, III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, K. Hoebe, O. Schneewind, D. Walker, B. Beutler, L. Teyton, P.B. Savage, and A. Bendelac, Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections, Nature, 434: 525–529, 2005.
   PubMed Web of Science ®Google Scholar
• G. De Libero and L. Mori, Recognition of lipid antigens by T cells, Nat. Rev. Immunol., 5: 485–496, 2005.
   PubMed Web of Science ®Google Scholar
• Z. Trobonjaca, F. Leithauser, P. Moller, R. Schirmbeck, and J. Reimann, Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells. J. Immunol., 167: 1413–1422, 2001.
   Google Scholar
• H. Kitamura, K. Iwakabe, T. Yahata, S. Nishimura, A. Ohta, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. Van L. Kaer, T. Kawano, M. Taniguchi, and T. Nishimura, The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells, J. Exp. Med., 189: 1121–1128, 1999.
   PubMed Web of Science ®Google Scholar
• Y. Hayakawa, K. Takeda, H. Tagita, L. Van Kaer, I. Saiki, and K. Okumura, Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways, J. Immunol., 166: 6012–6018, 2001.
   PubMed Web of Science ®Google Scholar
• E. Duvall, A.H. Wyllie, and R.G. Morris, Macrophage recognition of cells undergoing programmed cell death (apoptosis) Immunology, 56: 351–358, 1985.
   PubMed Web of Science ®Google Scholar
• K. Shortman and Y.J. Liu, Mouse and human dendritic cell subtypes, Nat. Rev. Immunol., 2: 151–161, 2002.
   PubMed Web of Science ®Google Scholar
• U. Boehm, T. Klamp, M. Groot, and J.C. Howard, Cellular responses to interferon-gamma, Annu. Rev. Immunol., 15: 749–795, 1997.
   PubMed Web of Science ®Google Scholar
• B.A. O'Brien, X. Geng, C.H. Orteu, Y. Huang, M. Ghoreishi, Y. Zhang, J.A. Bush, G. Li, D.T. Finegood, and J.P. Dutz, A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse, J. Autoimmun., 26: 104–115, 2006.
   PubMed Web of Science ®Google Scholar
• M. Skold, X. Xiong, P.A. Illarionov, G.S. Besra, and S.M. Behar, Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation, J. Immunol., 175: 3584–3593, 2005.
   PubMedGoogle Scholar
• W. Xu, A. Roos, N. Schlagwein, A.M. Woltman, M.R. Daha, and C. van Kooten, IL-10-producing macrophages preferentially clear early apoptotic cells, Blood, 107: 4930–4937, 2006.
   PubMed Web of Science ®Google Scholar
• H.H. Lin, D.E. Faunce, M. Stacey, A. Terajewicz, T. Nakamura, J. Zhang-Hoover, M. Kerley, M.L. Mucenski, S. Gordon, and J. Stein-Streilein, The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance, J. Exp. Med., 201: 1615–1625, 2005.
   PubMed Web of Science ®Google Scholar
• K.H. Sonoda and J. Stein-Streilein, CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance, Eur. J. Immunol., 32: 848–857, 2002.
   PubMed Web of Science ®Google Scholar
• T.J. D'Orazio and J.Y. Niederkorn, Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID) Immunology, 95: 47–55, 1998.
   PubMed Web of Science ®Google Scholar
• S.H. Park, J.H. Roark, and A. Bendelac, Tissue-specific recognition of mouse CD1 molecules, J. Immunol., 160: 3128–3134, 1998.
   PubMed Web of Science ®Google Scholar
• F.D. Shi, H.G. Ljunggren, and N. Sarvetnick, Innate immunity and autoimmunity: From self-protection to self-destruction, Immunology, 22: 97–101, 2001.
   Google Scholar
• S.B. Wilson, S.C. Kent, K.T. Patton, T. Orban, R.A. Jackson, M. Exley, S. Porcelli, D.A. Schatz, M.A. Atkinson, S.P. Balk, J.L. Strominger, and D.A. Hafler, Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes, Nature, 391: 177–181, 1998.
   PubMed Web of Science ®Google Scholar
• K. Oh, S. Kim, S.H. Park, H. Gu, D. Roopenian, D.H. Chung, Y.S. Kim, and D.S. Lee, Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity, J. Immunol., 174: 2030–2036, 2005.
   Google Scholar
• D. Zeng, D. Lewis, S. Dejbakhsh-Jones, F. Lan, M. Garcia-Ojeda, R. Sibley, and S. Strober, Bone marrow NK1.1(−) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease, J. Exp. Med., 189: 1073–1081, 1999.
   PubMed Web of Science ®Google Scholar
• Y. Chung, W.S. Chang, S. Kim, and C.Y. Kang, NKT cell ligand alpha-galactosylceramide blocks the induction of oral tolerance by triggering dendritic cell maturation, Eur. J. Immunol., 34: 2471–2479, 2004.
   Google Scholar
• T. De Smedt, M. Van Mechelen, G. De Becker, J. Urbain, O. Leo, and M. Moser, Effect of interleukin-10 on dendritic cell maturation and function, Eur. J. Immunol., 27: 1229–1235, 1997.
   PubMed Web of Science ®Google Scholar